Strategy Inc. Reports Strong Q4 Earnings, Shares Surge
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Should l Buy MSTR?
Source: Benzinga
- Strong Earnings Report: Strategy Inc. reported adjusted earnings per share of $16.37 for Q4, surpassing the consensus estimate of $10.96, indicating a significant improvement in profitability that boosts investor confidence.
- Revenue Growth: The company achieved revenue of $122.98 million in Q4, a 1.9% year-over-year increase, with subscription services revenue rising 62.1% to $51.8 million, reflecting strong performance in digital services that may drive sustained future growth.
- Bitcoin Holdings: As of February 1, Strategy Inc. held approximately 713,502 bitcoins at a total cost of $54.26 billion, averaging $76,052 per bitcoin, showcasing its strategic positioning in digital asset investments despite facing unrealized losses.
- Market Dynamics Analysis: Despite a 18.36% increase in stock price to $126.63, the current price remains below both the 20-day and 100-day simple moving averages, indicating a bearish trend in the short term, prompting investors to monitor key support at $104 and resistance at $155 closely.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MSTR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MSTR
Wall Street analysts forecast MSTR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MSTR is 453.17 USD with a low forecast of 229.00 USD and a high forecast of 705.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
12 Buy
2 Hold
0 Sell
Strong Buy
Current: 106.990
Low
229.00
Averages
453.17
High
705.00
Current: 106.990
Low
229.00
Averages
453.17
High
705.00
About MSTR
Strategy Inc., formerly MicroStrategy Incorporated, is a bitcoin treasury and business intelligence company. The Company provides cloud-native, artificial intelligence (AI)-powered enterprise analytics software to thousands of global customers. The Company’s Strategy ONE platform provides access to AI-powered workflows, unlimited data sources, cloud-native technologies, and performance to speed up time from data to action. Strategy One delivers visualization, reporting, and embedded analytics capabilities across retail, banking, technology, manufacturing, insurance, consulting, healthcare, telecommunications, and the public sector. Its Strategy Mosaic is a universal intelligence layer that provides enterprises with consistent definitions and governance across data sources, regardless of where that data resides or which tools access it. The Strategy Mosaic offers data clarity and connection by eliminating trade-offs between flexibility, control, and speed.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Reaction: The corrected strategy has led to a 5% gain in the pre-market following the release of results.
- Impact of Results: The results have positively influenced investor sentiment, contributing to the market's upward movement.
See More
- Severe Earnings Loss: Strategypress reported a Q4 2024 GAAP EPS of -$42.93, missing expectations by $21.94, indicating increased pressure in the digital asset market that may undermine investor confidence.
- Digital Asset Impairment: The company faced $1 billion in digital asset impairment losses for the fourth quarter, reflecting significant challenges in asset valuation prior to the accounting model change, which could lead to future financial uncertainty.
- Slight Revenue Growth: Q4 revenue reached $122.99 million, up 1.9% year-over-year and beating market expectations by $4.52 million, suggesting some revenue growth potential even in a challenging market environment.
- Bitcoin Holdings Overview: Strategypress holds 713,502 bitcoins at a total cost of $54.26 billion, averaging $76,052 per bitcoin, and achieved a 22.8% BTC yield in FY2025, demonstrating its long-term strategic commitment to digital asset investment.
See More
- Support Level Formation: In May 2024, when Strategy's stock price fell to around $105, a surge of buyers entered the market, leading to a reversal and highlighting the significance of this support level.
- Trader Sentiment: Many traders who sold near $105 regretted their decisions and opted to buy back shares when the price dropped again, reinforcing the support at this level.
- Recurring Pattern: In August 2024, as Strategy's stock price dropped back to $105, a significant number of buy orders emerged, forming support once more, followed by a rally, indicating strong market interest in this price point.
- Potential Uptrend: Should buyers begin bidding higher than the selling prices, it could push the stock price upward, creating a new uptrend, mirroring the previous two occurrences at this critical level.
See More
- Strong Earnings Report: Strategy Inc. reported adjusted earnings per share of $16.37 for Q4, surpassing the consensus estimate of $10.96, indicating a significant improvement in profitability that boosts investor confidence.
- Revenue Growth: The company achieved revenue of $122.98 million in Q4, a 1.9% year-over-year increase, with subscription services revenue rising 62.1% to $51.8 million, reflecting strong performance in digital services that may drive sustained future growth.
- Bitcoin Holdings: As of February 1, Strategy Inc. held approximately 713,502 bitcoins at a total cost of $54.26 billion, averaging $76,052 per bitcoin, showcasing its strategic positioning in digital asset investments despite facing unrealized losses.
- Market Dynamics Analysis: Despite a 18.36% increase in stock price to $126.63, the current price remains below both the 20-day and 100-day simple moving averages, indicating a bearish trend in the short term, prompting investors to monitor key support at $104 and resistance at $155 closely.
See More
- Dow Jones Performance: The Dow Jones index rose over 700 points on Friday, indicating a strong market rebound that reflects investor optimism about economic recovery, which could further drive consumer spending and investment.
- Strategic Shares Surge: Strategy shares jumped 14.1% to $122.56 on Friday, signaling a positive market outlook for the company and potentially attracting more investor interest in its future growth prospects.
- Overall Market Trend: The overall rise in U.S. stocks suggests a restoration of investor confidence, which may lead to increased capital inflows into the stock market, thereby promoting economic growth and corporate earnings.
- Market Data Source: This market update is provided by Benzinga APIs, highlighting improved market information transparency that aids investors in making more informed decisions.
See More
- Strategy Stock Surge: Strategy (MSTR) shares jumped 9% in premarket trading despite posting a Q4 2025 GAAP EPS of -$42.93, significantly missing the -$20.99 analyst estimate due to unrealized losses on bitcoin holdings, which overshadowed a modest increase in software revenue and widened losses from -$3.03 in the same quarter last year.
- Pfizer Drug Application: Pfizer (PFE) shares were flat before the opening bell after the FDA granted priority review for its marketing application seeking label expansion for Hympavzi, a hemophilia therapy currently available for patients aged 12 and older, indicating potential growth in the hemophilia treatment market.
- Hims & Hers Stock Decline: Hims & Hers Health (HIMS) shares fell approximately 7% in early trading after FDA Commissioner announced swift action against companies mass-marketing illegal copycat drugs, which could impact Hims & Hers' business model that offers discounted compounded versions of Novo Nordisk's weight-loss therapy.
- Philip Morris Mixed Results: Philip Morris (PM) shares slipped 2.4% in premarket trading after reporting mixed Q4 results, with a non-GAAP EPS of $1.70 meeting estimates, but revenue of $10.36 billion, up 6.7% year-over-year, missed expectations by $40 million, while the company forecasts 2026 EPS between $7.87 and $8.02 with organic revenue growth of 5% to 7%.
See More











